Back
Context Therapeutics Stock Predictions
Sponsored
CNTX
Sponsored
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
66
CNTX
Context Therapeutics
Last Price:
2.30
Seasonality Move:
-29.9%
7 Day Trial
ALL ACCESS PASS
$
7
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund managerContext Therapeutics Stock Forecast
-
Is Context Therapeutics Stock Undervalued?
The current Context Therapeutics [CNTX] share price is $2.22. The Score for CNTX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal. - CNTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Context Therapeutics Stock Go Up Next Year?
Data Unavailable
Context Therapeutics Stock Rating
Data Unavailable
Context Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
contexttherapeutics.com
52-Week Data
52-Week High:
2.75
52-Week Low:
0.77
Prediction Charts
Market Cap:
166.5M
Price in USD:
2.22
Volume:
38.14K
Beta:
2.28
Technical Analysis
SMA50:
2.30
SMA100:
2.09
SMA200:
1.62
52-Wk Change:
136.17%
Stock Predictions
-
Is Context Therapeutics stock public?
Yes, Context Therapeutics is a publicly traded company. -
What is the Context Therapeutics stock quote today?
The Context Therapeutics stock price is 2.22 USD today. -
How to buy Context Therapeutics stock online?
You can buy Context Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-30 | 2.47 | 2.46 | 2.49 | 2.43 |
Sep-3 | 2.46 | 2.44 | 2.50 | 2.42 |
Sep-4 | 2.45 | 2.43 | 2.55 | 2.34 |
Sep-5 | 2.40 | 2.28 | 2.44 | 2.28 |
Sep-6 | 2.30 | 2.29 | 2.38 | 2.21 |
Sep-9 | 2.31 | 2.14 | 2.31 | 2.10 |
Sep-10 | 2.12 | 2.13 | 2.19 | 2.09 |
Sep-11 | 2.14 | 2.14 | 2.18 | 2.05 |
Sep-12 | 2.11 | 2.14 | 2.25 | 2.11 |
Sep-13 | 2.21 | 2.09 | 2.23 | 2.03 |
Sep-16 | 2.04 | 2.08 | 2.14 | 2.03 |
Sep-17 | 2.05 | 2.08 | 2.10 | 2.04 |
Sep-18 | 2.10 | 1.96 | 2.12 | 1.94 |
Sep-19 | 1.96 | 2.22 | 2.23 | 1.96 |
Context Therapeutics Earnings
Data Unavailable
Context Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.14 per share, and a decrease next year of $0.02 per share.
* Context Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.